-The Indian Express As the tenure of the incumbent draws to a close, let's debate the institution's structure and powers It is time for the selection of a new comptroller and auditor general as the tenure of the incumbent draws to a close on May 22. Traditionally, the CAG has been an unseen agency, churning out audit report after audit report on every department supported by government funds every year. The last...

-The Hindu Business Line   The general tendency among Indian policy makers currently is to blame international price movements for the rise in prices of essential food items in India. The extent to which this claim is valid is assessed by examining the specific case of wheat. It is no secret that Indian food prices are increasingly affected by international prices. Ever since 2002, when all quantitative restrictions on Indian imports of agricultural...

-The Hindu Business Line Fresh guidelines issued on procurement details, disclosure of CAG reports Public-private partnerships (PPPs) will soon come under the ambit of the RTI (right to information) as per a fresh set of guidelines issued by the Department of Personnel and Training (DoPT) on April 15. According to the guidelines on suo motu disclosure under Section 4 of RTI Act, 2005, the DoPT says since public services are proposed to be...

-The Times of India In a significant move towards transparency, the government on Tuesday said all public authorities should proactively disclose information related to public private partnerships (PPP) projects on their websites. Though the disclosure will be voluntary, this marks a shift from the Centre's stand for the last two years when it stonewalled Central Information Commission (CIC)'s recommendation seeking disclosure of PPP projects and will herald greater transparency. Guidelines issued by the...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...